Navigation Links
Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
Date:2/19/2008

c acid. Despite this, the U.S. market for topical prescription retinoids, such as retinoic acid, for acne treatment exceeds US$300 million annually.

"A new formulation with the ability to deliver greater absorption of retinoic acid, reduce irritation and dryness and limit systemic circulation would significantly increase practitioners' flexibility in prescribing the product," said Harry Rosen, President & CEO of Phosphagenics. "It would enable physicians to prescribe greater doses of retinoic acid and/or maintain current dosing while achieving improved efficacy and substantially limiting adverse effects. Such a product would have the potential to expand the current market, and would likely capture a significant proportion of the existing market.

"In our previously completed pre-clinical studies, we were able to consistently demonstrate an increase in retinoic acid delivered, a reduction in irritation scores, as well as limit the delivery of retinoic acid into the systemic circulation, which is important because of its side effects. Our objective is to replicate these results in our human trial and deliver a safer, more effective acne treatment to consumers as quickly as possible."

In addition to retinoic acid, Phosphagenics is developing a number of other product candidates utilizing its targeted, non-systemic delivery technology, including multiple anti-inflammatory and analgesic compounds.

About Phosphagenics Limited

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
2. Nestle Nutrition and Phosphagenics to Commence Phospha E(R) Phase 2 Clinical Trial
3. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
4. Phosphagenics to Commence Phase 2 TPM/Insulin Clinical Trial
5. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
6. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
7. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
8. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
9. Northwestern Memorial Transplant Program Initiates New Study
10. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
11. SGX Initiates Phase I Trials for SGX523
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... California , July 30, 2014 ... technology and CUDA programming expertise to big data, ... markets  eInfochips, a leading engineering R&D ... clients to develop NVIDIA GPU-powered solutions for ... high-performance computing (HPC), industrial , ...
(Date:7/30/2014)... 2014 Die Apex Medical Corporation ... Bereich Atemtherapie- und Druckzonenprodukte, gibt bekannt, dass ... Deutschland anfechten werden. Dieses hat entschieden, dass ... von ResMed verletze. Apex weist darauf hin, ... verschiedene Patente von ResMed Anfechtungen wegen Nichtigkeit ...
(Date:7/29/2014)... Israel , July 30, 2014  Immune ... Stockholm : "IMNP."; "Immune" or "the ... of patients for a Phase II proof of concept ... in the treatment of moderate to severe bullous pemphigoid. ... receive two bertilimumab infusions, at a dose of 10 ...
Breaking Medicine Technology:eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 2Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 3Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 4Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin 5
... is little evidence to support the use of atypical ... approved purposes, even though many clinicians continue to commonly ... to a new report from the U.S. Department of ... and Quality (AHRQ). An article based on information in ...
... The Houston Business Journal recently announced that eCardio Diagnostics ... Fast 100, which included a distinguished list of 100 of ... eCardio was ranked No. 17 with a two-year growth ... to receive this prestigious award. "There were so ...
Cached Medicine Technology:"Off-Label" Use of Antipsychotic Drugs for Some Conditions Not Supported By Evidence 2eCardio Among Honorees of the Houston Business Journal's Fast 100 List for Second Consecutive Year 2
(Date:7/30/2014)... 2014 Running season is in full ... aims to help runners keep running. Dr Shoshany will ... continue training. He has recently began implementing an expanded, ... Cold Laser Therapy, Graston technique and kinesiology taping to ... Dr Shoshany often combines chiropractic , and physical ...
(Date:7/30/2014)... It is often said the reason that most people ... life is because they only use about ten per cent of ... belief is only an erroneous myth propagated as an excuse ... only “smarter”. , So, success in life is defined not just ... hard for that success. Thankfully, some people have finally figured out ...
(Date:7/30/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on snacks . , ... snacks are recalled because they contain organic ... with salmonella. Salmonella can cause serious, fatal infections in ... can cause abdominal pain, vomiting, nausea, diarrhea, or fever. ...
(Date:7/30/2014)... With the accelerated aging of the ... as well as the improved medical care facilities ... industry has been developing quickly, especially in vitro ... in vitro diagnostics market size reached RMB22.98 billion, ... diagnostic reagents. , Chinese in vitro diagnostic ...
(Date:7/30/2014)... City, OK (PRWEB) July 30, 2014 ... City, but it’s Founders, Amber Clour and Ryan Fightmaster ... worldwide level. , Officially launched on July 26th of ... provide real support for others living the diabetic life. ... had, dreams pursued and inspirations, they believe other diabetics ...
Breaking Medicine News(10 mins):Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 2Health News:Chiropractor Helping Runners Keep Going with New Integrated Treatment Protocols 3Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 2Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 3Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Various Snacks by Dancing Star Recalled: AttorneyOne Monitors and Keeps Consumers Informed 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 2Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 3Health News:China Diagnostic Reagent Industry (biochemical, molecular & immunodiagnostic) 2016 Forecasts in New Research Report at ChinaMarketResearchReports.com 4Health News:Strangers Come Together to Form Diabetes Website: Real Messages of Hope and Inspiration 2
... say, Montelukast, a leukotriene-receptor antagonist (leukotrienes mediate inflammation // ... reactions), decreased incidents of asthma in young children by ... ,Researchers conducted a one-year study involving 549 children ... 278 of the children received low-dose montelukast once a ...
... considered till now that after delivery depressions, that had plagued new ... trauma of the delivery. As a result of this belief, many ... depression. A new study that comes in the recent issue of ... ,According to Deirdre Murphy of Dundee University, who had led ...
... treat patients with acute traumatic brain injury, may lead to ... & Tropical Medicine. ,British researchers had studied the ... brain injury. The study was conducted to see the effect ... results showed that there seems to be an increase in ...
... their mothers to see if there was a link between ... life and children's antisocial behavior by age 7 , researchers ... problems with conduct and more antisocial behavior . ,Results ... birth and the likeliness of antisocial behavior in children by ...
... to a recent study researchers say those in the ... // an increased risk of suicidal behavior . ... and other clinical conditions were studied. Patients taking SSRIs ... taking placebo. Researchers say they found no difference ...
... Quetiapine, a drug used to treat agitation in patients ... say researchers based on findings of a recent study ... patients were observed . Twenty-six of the patients received ... rivastigmine (a cholinesterase inhibitor also known as Exelon), and ...
Cached Medicine News:
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: